메뉴 건너뛰기




Volumn 80, Issue 3, 1998, Pages 382-387

Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; ORAL CONTRACEPTIVE AGENT; PROTEIN C; PROTEIN S; PROTHROMBIN;

EID: 0031725447     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615216     Document Type: Article
Times cited : (71)

References (47)
  • 1
    • 50549167392 scopus 로고
    • Pulmonary embolism
    • Jordan WM. Pulmonary embolism. Lancet 1961; 2: 1146-7.
    • (1961) Lancet , vol.2 , pp. 1146-1147
    • Jordan, W.M.1
  • 2
    • 0014962032 scopus 로고
    • Thromboembolic disease and the steroidal content of oral contraceptives a report to the committee on safety of drugs
    • Inman WHW, Vessey MP, Westerholm B, Engelund A, Thromboembolic disease and the steroidal content of oral contraceptives a report to the committee on safety of drugs. British Medical Journal 1970; 2: 203-9.
    • (1970) British Medical Journal , vol.2 , pp. 203-209
    • Inman, W.H.W.1    Vessey, M.P.2    Westerholm, B.3    Engelund, A.4
  • 3
    • 0023904587 scopus 로고
    • Risks and mechanism of cardiovascular events in users of oral contraceptives
    • Meade TW. Risks and mechanism of cardiovascular events in users of oral contraceptives. Am J Obstet Gynecol 1988; 158: 1646-52.
    • (1988) Am J Obstet Gynecol , vol.158 , pp. 1646-1652
    • Meade, T.W.1
  • 5
    • 0002961445 scopus 로고    scopus 로고
    • Evidence that currently available pills are associated with cardiovascular disease: Venous disease
    • Hannaford PC, Webb AMC. (Carnforth, UK: Parthenon Publishing)
    • Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Evidence that currently available pills are associated with cardiovascular disease: venous disease. In: Hannaford PC, Webb AMC. Evidence-guided Prescribing of the Pill 1996: 61-76 (Carnforth, UK: Parthenon Publishing).
    • (1996) Evidence-guided Prescribing of the Pill , pp. 61-76
    • Bloemenkamp, K.W.M.1    Rosendaal, F.R.2    Helmerhorst, F.M.3    Vandenbroucke, J.P.4
  • 6
    • 0029564931 scopus 로고
    • Venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case-control study
    • World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case-control study. Lancet 1995; 346: 1575-82.
    • (1995) Lancet , vol.346 , pp. 1575-1582
  • 7
    • 13344260005 scopus 로고
    • Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease
    • World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995; 346: 1582-8.
    • (1995) Lancet , vol.346 , pp. 1582-1588
  • 8
    • 0029586002 scopus 로고
    • Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components
    • Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995; 346: 1589-93.
    • (1995) Lancet , vol.346 , pp. 1589-1593
    • Jick, H.1    Jick, S.S.2    Gurewich, V.3    Myers, M.W.4    Vasilakis, C.5
  • 9
    • 0029609256 scopus 로고
    • Enhancement by factor V Leiden mutation of risk of deepvein thrombosis associated with oral contraceptives containing third-generation progestagen
    • Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, Buller HR, Vandenbroucke JP. Enhancement by factor V Leiden mutation of risk of deepvein thrombosis associated with oral contraceptives containing third-generation progestagen. Lancet 1995; 346: 1593-6.
    • (1995) Lancet , vol.346 , pp. 1593-1596
    • Bloemenkamp, K.W.M.1    Rosendaal, F.R.2    Helmerhorst, F.M.3    Buller, H.R.4    Vandenbroucke, J.P.5
  • 10
    • 0029671042 scopus 로고    scopus 로고
    • Third generation oral contraceptives and risk of venous thromboembolic disorders: An international case-control study
    • Spitzer WO, Lewis MA, Heinemann LAJ, Thorogood M, MacRae KD on behalf of Transnational Research Group on Oral Contraceptives and the Health of Young women. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. BMJ 1996; 312: 83-8.
    • (1996) BMJ , vol.312 , pp. 83-88
    • Spitzer, W.O.1    Lewis, M.A.2    Heinemann, L.A.J.3    Thorogood, M.4    MacRae, K.D.5
  • 11
    • 0000549495 scopus 로고
    • Pathogenesis of venous thrombosis
    • Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD (eds). New York: Churchill-Livingstone
    • Thomas DP. Pathogenesis of venous thrombosis. In: Haemostasis and Thrombosis, 3rd edition. Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD (eds). New York: Churchill-Livingstone 1994; pp. 1335-47.
    • (1994) Haemostasis and Thrombosis, 3rd Edition , pp. 1335-1347
    • Thomas, D.P.1
  • 12
    • 0002596183 scopus 로고
    • Epidemiology of pulmonary embolism and deep venous thrombosis
    • Bloom AL, Forbes CD, Thomas DP, Tuddenham HGD (eds). New York: ChurchillLivingstone
    • Goldhaber SZ. Epidemiology of pulmonary embolism and deep venous thrombosis. In: Haemostasis and Thrombosis. 3rd edition. Bloom AL, Forbes CD, Thomas DP, Tuddenham HGD (eds). New York: ChurchillLivingstone 1994; pp. 1327-33.
    • (1994) Haemostasis and Thrombosis. 3rd Edition , pp. 1327-1333
    • Goldhaber, S.Z.1
  • 13
    • 0028213422 scopus 로고
    • New progestogens in oral contraception
    • Fotherby K, Caldwell ADS. New progestogens in oral contraception. Contraception 1994; 49: 1-32.
    • (1994) Contraception , vol.49 , pp. 1-32
    • Fotherby, K.1    Caldwell, A.D.S.2
  • 14
    • 0028116025 scopus 로고
    • Low-dose combined oral contraceptives
    • Robinson GE. Low-dose combined oral contraceptives. British J Obstet and Gynaecol 1994; 101: 1036-42.
    • (1994) British J Obstet and Gynaecol , vol.101 , pp. 1036-1042
    • Robinson, G.E.1
  • 15
    • 0021885167 scopus 로고
    • Effects of oral contraceptives on blood coagulation. A review
    • Beller FK, Ebert C. Effects of oral contraceptives on blood coagulation. A review. Obstetrical and Gynecological Survey 1985; 40: 425-36.
    • (1985) Obstetrical and Gynecological Survey , vol.40 , pp. 425-436
    • Beller, F.K.1    Ebert, C.2
  • 16
    • 0030756915 scopus 로고    scopus 로고
    • Effect of oral contraceptives on haemostasis variables
    • Kluft C, Lansink M. Effect of oral contraceptives on haemostasis variables. Thromb Haemost 1997; 78: 315-26.
    • (1997) Thromb Haemost , vol.78 , pp. 315-326
    • Kluft, C.1    Lansink, M.2
  • 17
    • 0020040466 scopus 로고
    • Oral contraceptives and blood coagulation: A critical review
    • Mammen EF. Oral contraceptives and blood coagulation: a critical review. Am J Obstet Gynecol 1982; 142: 781-90.
    • (1982) Am J Obstet Gynecol , vol.142 , pp. 781-790
    • Mammen, E.F.1
  • 18
    • 0020054168 scopus 로고
    • Oral contraceptives, clotting factors, and thrombosis
    • Meade TW. Oral contraceptives, clotting factors, and thrombosis. Am J Obstet Gynecol 1982; 142: 758-61.
    • (1982) Am J Obstet Gynecol , vol.142 , pp. 758-761
    • Meade, T.W.1
  • 19
    • 0026664240 scopus 로고
    • Estrogen-associated thromboembolism
    • Wessler S. Estrogen-associated thromboembolism. Ann Epidemiol 1992; 2: 439-43.
    • (1992) Ann Epidemiol , vol.2 , pp. 439-443
    • Wessler, S.1
  • 21
    • 0028931717 scopus 로고
    • High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
    • see comments
    • Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) [see comments]. Blood 1995; 85: 1504-8.
    • (1995) Blood , vol.85 , pp. 1504-1508
    • Rosendaal, F.R.1    Koster, T.2    Vandenbroucke, J.P.3    Reitsma, P.H.4
  • 22
    • 0028029477 scopus 로고
    • Inceased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
    • Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaal FR. Inceased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 334: 1453-7.
    • (1994) Lancet , vol.334 , pp. 1453-1457
    • Vandenbroucke, J.P.1    Koster, T.2    Briët, E.3    Reitsma, P.H.4    Bertina, R.M.5    Rosendaal, F.R.6
  • 23
    • 0028239952 scopus 로고
    • Syndromes of hypercoagulability and Thrombosis: A review
    • Bick RL, Pegram M. Syndromes of hypercoagulability and Thrombosis: a review. Seminars in Thrombosis and Hemostasis 1994; 20 (1): 109-32.
    • (1994) Seminars in Thrombosis and Hemostasis , vol.20 , Issue.1 , pp. 109-132
    • Bick, R.L.1    Pegram, M.2
  • 24
    • 0026231412 scopus 로고
    • The role of drugs, paticularly oral contraceptives, in triggering thrombosis in congenital defects of coagulation inhibitors: A studs of six patients
    • Girolami A, Simioni P, Girolami B, Zanardi S. The role of drugs, paticularly oral contraceptives, in triggering thrombosis in congenital defects of coagulation inhibitors: a studs of six patients. Blood Coagulation and Fibrinolysis 1991; 2: 673-8.
    • (1991) Blood Coagulation and Fibrinolysis , vol.2 , pp. 673-678
    • Girolami, A.1    Simioni, P.2    Girolami, B.3    Zanardi, S.4
  • 25
    • 0026519717 scopus 로고
    • Oral contraceptives caused thrombosis in a monoovular twin with protein C deficiency, while the other, without medication, remained asymptomatic
    • Girolami A, Simioni P, Sartori MT, Zanardi S, Oral contraceptives caused thrombosis in a monoovular twin with protein C deficiency, while the other, without medication, remained asymptomatic [letter]. Blood Coagul Fibrinolysis 1992; 3: 119-20.
    • (1992) Blood Coagul Fibrinolysis , vol.3 , pp. 119-120
    • Girolami, A.1    Simioni, P.2    Sartori, M.T.3    Zanardi, S.4
  • 26
    • 0028324624 scopus 로고
    • Thrombotic risk of women with hereditary anlithrombin III-, protein C- and protein S-deficiency taking oral contraceptive medication. The GTH Study Group on Natural Inhibitors
    • Pabinger I, Schneider B. Thrombotic risk of women with hereditary anlithrombin III-, protein C-and protein S-deficiency taking oral contraceptive medication. The GTH Study Group on Natural Inhibitors. Thromb Haemost 1994; 71: 548-52.
    • (1994) Thromb Haemost , vol.71 , pp. 548-552
    • Pabinger, I.1    Schneider, B.2
  • 27
    • 0026667740 scopus 로고
    • Recent advances in understanding clotting and evaluating patients with recurrent thrombosis
    • Alving BM, Comp PC. Recent advances in understanding clotting and evaluating patients with recurrent thrombosis. Am J Obstet Gynecol 1992; 167: 1184-91.
    • (1992) Am J Obstet Gynecol , vol.167 , pp. 1184-1191
    • Alving, B.M.1    Comp, P.C.2
  • 28
    • 0027520285 scopus 로고
    • Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
    • Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-6.
    • (1993) Lancet , vol.342 , pp. 1503-1506
    • Koster, T.1    Rosendaal, F.R.2    De Ronde, H.3    Briët, E.4    Vandenbroucke, J.P.5    Bertina, R.M.6
  • 29
    • 0029033740 scopus 로고
    • Protein C deficiency in a controlled series of unselected outpatients: An infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study)
    • Koster T, Rosendaal FR, Briët E, Van der Meer FJM, Colly LP, Trienekens PH, Poort SR, Vandenbroucke JP. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood 1995; 85: 2756-61.
    • (1995) Blood , vol.85 , pp. 2756-2761
    • Koster, T.1    Rosendaal, F.R.2    Briët, E.3    Van Der Meer, F.J.M.4    Colly, L.P.5    Trienekens, P.H.6    Poort, S.R.7    Vandenbroucke, J.P.8
  • 30
    • 0028342850 scopus 로고
    • Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms, Leiden thrombophilia Study
    • Koster T, Rosendaal FR, Reitsma PH, Van der Velden PA, Briët E, Vandenbroucke JP. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms, Leiden thrombophilia Study. Thromb Haemost 1994; 71: 719-22.
    • (1994) Thromb Haemost , vol.71 , pp. 719-722
    • Koster, T.1    Rosendaal, F.R.2    Reitsma, P.H.3    Van Der Velden, P.A.4    Briët, E.5    Vandenbroucke, J.P.6
  • 31
    • 0028814316 scopus 로고
    • Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis
    • Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345: 152-5.
    • (1995) Lancet , vol.345 , pp. 152-155
    • Koster, T.1    Blann, A.D.2    Briët, E.3    Vandenbroucke, J.P.4    Rosendaal, F.R.5
  • 32
    • 0028234054 scopus 로고
    • John Hageman's factor and deep-vein thrombosis: Leiden thrombophilia Study
    • Koster T, Rosendaal FR, Briët E, Vandenbroucke JP. John Hageman's factor and deep-vein thrombosis: Leiden thrombophilia Study. Br J Haematol 1994; 87: 422-4.
    • (1994) Br J Haematol , vol.87 , pp. 422-424
    • Koster, T.1    Rosendaal, F.R.2    Briët, E.3    Vandenbroucke, J.P.4
  • 33
    • 0028651903 scopus 로고
    • Laboratory diagnosis of APC-resistance: A critical evaluation of the test and the devlopment of diagnostic criteria
    • De Ronde H, Bertina RM. Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the devlopment of diagnostic criteria. Thromb Haemost 1994; 72: 880-6.
    • (1994) Thromb Haemost , vol.72 , pp. 880-886
    • De Ronde, H.1    Bertina, R.M.2
  • 34
    • 0029909078 scopus 로고    scopus 로고
    • Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contra-ceptives
    • Quehenberger P, Loner U, Kapiotis S, Handler S, Schneider B, Huber J, Speiser W. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contra-ceptives. Thromb Haemost 1996; 76 (5): 729-34.
    • (1996) Thromb Haemost , vol.76 , Issue.5 , pp. 729-734
    • Quehenberger, P.1    Loner, U.2    Kapiotis, S.3    Handler, S.4    Schneider, B.5    Huber, J.6    Speiser, W.7
  • 35
    • 0027199437 scopus 로고
    • Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 μg to 20 μg in oral contraceptives containing desogestrel
    • Basdevant A, Conard J, Pelissier C, Guyene TT, Lapousterle C, Mayer M, Gran BG, Degrelle H. Hemostatic and metabolic effects of lowering the ethinyl-estradiol dose from 30 μg to 20 μg in oral contraceptives containing desogestrel. Contraception 1993; 48: 193-204.
    • (1993) Contraception , vol.48 , pp. 193-204
    • Basdevant, A.1    Conard, J.2    Pelissier, C.3    Guyene, T.T.4    Lapousterle, C.5    Mayer, M.6    Gran, B.G.7    Degrelle, H.8
  • 36
    • 0023906144 scopus 로고
    • The effects of oestrogenadministration on the plasma free protein S and C4-b-binding protein
    • Melissari E, Kakkar VV. The effects of oestrogenadministration on the plasma free protein S and C4-b-binding protein. Thromb Res 1988; 49: 489-95.
    • (1988) Thromb Res , vol.49 , pp. 489-495
    • Melissari, E.1    Kakkar, V.V.2
  • 37
    • 0020026065 scopus 로고
    • The coagulation and fibrinolytic system in pregnancy and in the puerperium
    • Bellere FK, Ebert CH. The coagulation and fibrinolytic system in pregnancy and in the puerperium. Eur J Obstet Gynecol Reprod Biol 1982; 13: 177-97.
    • (1982) Eur J Obstet Gynecol Reprod Biol , vol.13 , pp. 177-197
    • Bellere, F.K.1    Ebert, C.H.2
  • 38
  • 39
    • 0030021994 scopus 로고    scopus 로고
    • A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 μg and 30 μg ethinylestradiol
    • Winkler UH, Schindler AE, Endrikat J, Dusterberg B. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 μg and 30 μg ethinylestradiol. Contraception 1996; 53: 75-84.
    • (1996) Contraception , vol.53 , pp. 75-84
    • Winkler, U.H.1    Schindler, A.E.2    Endrikat, J.3    Dusterberg, B.4
  • 40
    • 0027461705 scopus 로고
    • Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women
    • Petersen KR, Sidelmann J, Skouby SO, Jespersen J. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women. Am J Obstet Gynecol 1993; 168: 32-8.
    • (1993) Am J Obstet Gynecol , vol.168 , pp. 32-38
    • Petersen, K.R.1    Sidelmann, J.2    Skouby, S.O.3    Jespersen, J.4
  • 41
    • 0025164622 scopus 로고
    • Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid
    • Jespersen J, Petersen KR, Skouby SO. Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid. Am J Obstet Gynecol 1990; 163: 396-403.
    • (1990) Am J Obstet Gynecol , vol.163 , pp. 396-403
    • Jespersen, J.1    Petersen, K.R.2    Skouby, S.O.3
  • 42
    • 0028033324 scopus 로고
    • Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive
    • Cachrimanidou A-C, Hellberg D, Nilsson S, von Schoulz B, Crona N, Siegbahn A. Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive. Contraception 1994; 50: 153-65.
    • (1994) Contraception , vol.50 , pp. 153-165
    • Cachrimanidou, A.-C.1    Hellberg, D.2    Nilsson, S.3    Von Schoulz, B.4    Crona, N.5    Siegbahn, A.6
  • 43
    • 0028902902 scopus 로고
    • Sensitivity to activated protein C; Influence of oral contraceptoives and sex
    • Henkens CMA, Bom VJJ, Seinen AJ, Meer van der J. Sensitivity to activated protein C; Influence of oral contraceptoives and sex. Thromb Haemost 1995; 73 (3): 402-4.
    • (1995) Thromb Haemost , vol.73 , Issue.3 , pp. 402-404
    • Henkens, C.M.A.1    Bom, V.J.J.2    Seinen, A.J.3    Meer Van Der, J.4
  • 45
  • 47
    • 0030934739 scopus 로고    scopus 로고
    • Oral contraceptives and venous thrombosis; different sensitivities to activated protein C in women using second- and third generation oral contraceptives
    • Rosing J, Tans G, Nicolaes GAF, et al. Oral contraceptives and venous thrombosis; different sensitivities to activated protein C in women using second- and third generation oral contraceptives. Br J Haematol 1997; 97: 233-38.
    • (1997) Br J Haematol , vol.97 , pp. 233-238
    • Rosing, J.1    Tans, G.2    Nicolaes, G.A.F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.